Ideal candidates typically include: Adults with a BMI of 30 or higher (classified as obese) Adults with a BMI of 27 or higher who have at least one weight-related condition, such as type 2 diabetes, hypertension, high cholesterol, PCOS, or obstructive sleep apnea Individuals who have tried diet and exercise consistently but havent achieved meaningful weight loss Patients seeking a non-surgical, medication-based alternative to bariatric procedures People with insulin resistance, prediabetes, or blood sugar management challenges Semaglutide is not recommended for patients who are pregnant, breastfeeding, or planning to conceive, as well as those with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2
It is a tiny anchor before your stomach feels too empty
In its confirmatory trial, Leqembi was shown to reduce clinical decline in mild to moderate Alzheimers by 27%, while donanemab reduced decline in early symptomatic Alzheimers by up to 36%
Avoiding Deficiencies: The GLP-1 Vitamin Deficiency Challenge One of the most overlooked aspects of weight loss injections is the risk of a GLP-1 vitamin deficiency
Research shows that by using our compounds lab researchers get full quality control, detailed analytical data and research grade specifications so every scientific study is supported by compounds for controlled lab research and academic use